Trial Profile
The Effects of Early and Late Injection of Botulinum Toxin Type A on Upper Limb Function in Patients With Stroke
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 04 Oct 2022
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Stroke
- Focus Therapeutic Use
- 29 Sep 2022 Planned End Date changed from 1 Sep 2018 to 1 Sep 2025.
- 29 Sep 2022 Planned primary completion date changed from 1 Sep 2017 to 1 Sep 2023.
- 26 Oct 2015 New trial record